Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1962
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1963 1
1964 5
1966 3
1967 9
1968 12
1969 11
1970 15
1971 9
1972 13
1973 12
1974 11
1975 15
1976 13
1977 11
1978 18
1979 20
1980 13
1981 12
1982 13
1983 29
1984 17
1985 21
1986 25
1987 38
1988 76
1989 96
1990 96
1991 94
1992 124
1993 112
1994 104
1995 104
1996 87
1997 116
1998 107
1999 103
2000 137
2001 100
2002 94
2003 105
2004 160
2005 139
2006 146
2007 134
2008 129
2009 144
2010 169
2011 168
2012 162
2013 227
2014 198
2015 195
2016 164
2017 193
2018 174
2019 165
2020 156
2021 153
2022 173
2023 151
2024 142
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

5,027 results

Results by year

Filters applied: . Clear all
Page 1
Kaposiform hemangioendothelioma: current knowledge and future perspectives.
Ji Y, Chen S, Yang K, Xia C, Li L. Ji Y, et al. Orphanet J Rare Dis. 2020 Feb 3;15(1):39. doi: 10.1186/s13023-020-1320-1. Orphanet J Rare Dis. 2020. PMID: 32014025 Free PMC article. Review.
Kaposiform hemangioendothelioma (KHE) is a rare vascular neoplasm with high morbidity and mortality. The initiating mechanism during the pathogenesis of KHE has yet to be discovered. ...
Kaposiform hemangioendothelioma (KHE) is a rare vascular neoplasm with high morbidity and mortality. The initiating mechanism during …
Epithelioid Hemangioendothelioma: Update on Diagnosis and Treatment.
Rosenberg A, Agulnik M. Rosenberg A, et al. Curr Treat Options Oncol. 2018 Mar 15;19(4):19. doi: 10.1007/s11864-018-0536-y. Curr Treat Options Oncol. 2018. PMID: 29546487 Review.
Epithelioid hemangioendothelioma (EHE) is an extremely rare sarcoma, as such it can pose a clinical dilemma based solely on its rarity. ...
Epithelioid hemangioendothelioma (EHE) is an extremely rare sarcoma, as such it can pose a clinical dilemma based solely on its rarit …
Infantile haemangioma.
Léauté-Labrèze C, Harper JI, Hoeger PH. Léauté-Labrèze C, et al. Lancet. 2017 Jul 1;390(10089):85-94. doi: 10.1016/S0140-6736(16)00645-0. Epub 2017 Jan 13. Lancet. 2017. PMID: 28089471 Review.
With a prevalence of 4.5%, infantile haemangiomas are the most common benign tumours of infancy, arising in the first few weeks of life and exhibiting a characteristic sequence of growth and spontaneous involution. Most infantile haemangiomas do not require therapy. …
With a prevalence of 4.5%, infantile haemangiomas are the most common benign tumours of infancy, arising in the first few weeks of li …
The genetics of vascular tumours: an update.
Torrence D, Antonescu CR. Torrence D, et al. Histopathology. 2022 Jan;80(1):19-32. doi: 10.1111/his.14458. Histopathology. 2022. PMID: 34958509 Free PMC article. Review.
Recent molecular advances have shed significant light on the classification of vascular tumours. Except for haemangiomas, vascular lesions remain difficult to diagnose, owing to their rarity and overlapping clinical, radiographic and histological features across malignanci …
Recent molecular advances have shed significant light on the classification of vascular tumours. Except for haemangiomas, vascular le …
Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts.
Stacchiotti S, Miah AB, Frezza AM, Messiou C, Morosi C, Caraceni A, Antonescu CR, Bajpai J, Baldini E, Bauer S, Biagini R, Bielack S, Blay JY, Bonvalot S, Boukovinas I, Bovee JVMG, Boye K, Brodowicz T, Callegaro D, De Alava E, Deoras-Sutliff M, Dufresne A, Eriksson M, Errani C, Fedenko A, Ferraresi V, Ferrari A, Fletcher CDM, Garcia Del Muro X, Gelderblom H, Gladdy RA, Gouin F, Grignani G, Gutkovich J, Haas R, Hindi N, Hohenberger P, Huang P, Joensuu H, Jones RL, Jungels C, Kasper B, Kawai A, Le Cesne A, Le Grange F, Leithner A, Leonard H, Lopez Pousa A, Martin Broto J, Merimsky O, Merriam P, Miceli R, Mir O, Molinari M, Montemurro M, Oldani G, Palmerini E, Pantaleo MA, Patel S, Piperno-Neumann S, Raut CP, Ravi V, Razak ARA, Reichardt P, Rubin BP, Rutkowski P, Safwat AA, Sangalli C, Sapisochin G, Sbaraglia M, Scheipl S, Schöffski P, Strauss D, Strauss SJ, Sundby Hall K, Tap WD, Trama A, Tweddle A, van der Graaf WTA, Van De Sande MAJ, Van Houdt W, van Oortmerssen G, Wagner AJ, Wartenberg M, Wood J, Zaffaroni N, Zimmermann C, Casali PG, Dei Tos AP, Gronchi A. Stacchiotti S, et al. ESMO Open. 2021 Jun;6(3):100170. doi: 10.1016/j.esmoop.2021.100170. Epub 2021 Jun 2. ESMO Open. 2021. PMID: 34090171 Free PMC article. Review.
Epithelioid hemangioendothelioma (EHE) is an ultra-rare, translocated, vascular sarcoma. EHE clinical behavior is variable, ranging from that of a low-grade malignancy to that of a high-grade sarcoma and it is marked by a high propensity for systemic involvement. ...
Epithelioid hemangioendothelioma (EHE) is an ultra-rare, translocated, vascular sarcoma. EHE clinical behavior is variable, ranging f …
Vascular tumors.
Mansfield SA, Williams RF, Iacobas I. Mansfield SA, et al. Semin Pediatr Surg. 2020 Oct;29(5):150975. doi: 10.1016/j.sempedsurg.2020.150975. Epub 2020 Sep 16. Semin Pediatr Surg. 2020. PMID: 33069294 Review.
Treatment recommendations are summarized based on the current literature. Congenital and infantile hemangiomas are covered separately in a separate chapter in this issue....
Treatment recommendations are summarized based on the current literature. Congenital and infantile hemangiomas are covered separately …
Pseudomyogenic Hemangioendothelioma.
Al-Qaderi A, Mansour AT. Al-Qaderi A, et al. Arch Pathol Lab Med. 2019 Jun;143(6):763-767. doi: 10.5858/arpa.2017-0430-RS. Epub 2018 Dec 21. Arch Pathol Lab Med. 2019. PMID: 30576238 Free article. Review.
First described in 2003 as epithelioid-sarcoma-like hemangioendothelioma and later in 2011 as pseudomyogenic hemangioendothelioma, this rare vascular tumor is of intermediate malignant potential. ...This tumor lacks morphologic features of vascular differentiation b …
First described in 2003 as epithelioid-sarcoma-like hemangioendothelioma and later in 2011 as pseudomyogenic hemangioendothelioma
Pseudomyogenic hemangioendothelioma.
Horan NA, DiMaio DJ. Horan NA, et al. Cutis. 2017 Dec;100(6):E13-E16. Cutis. 2017. PMID: 29360904 Review.
Pseudomyogenic hemangioendothelioma (PMHE) is a rare vascular tumor that was added to the World Health Organization classification of soft tissue tumors. ...
Pseudomyogenic hemangioendothelioma (PMHE) is a rare vascular tumor that was added to the World Health Organization classification of …
Kasabach-merritt syndrome.
Maguiness S, Guenther L. Maguiness S, et al. J Cutan Med Surg. 2002 Jul-Aug;6(4):335-9. doi: 10.1177/120347540200600405. Epub 2002 Apr 15. J Cutan Med Surg. 2002. PMID: 11951132 Review.
Kasabach-Merritt syndrome is associated with kaposiform hemangioendothelioma (KHE) and tufted angioma (TA); these lesions, when associated with KMS, are locally invasive, aggressive vascular tumors. ...
Kasabach-Merritt syndrome is associated with kaposiform hemangioendothelioma (KHE) and tufted angioma (TA); these lesions, when assoc …
Vascular tumors of intermediate malignancy: An update.
Folpe AL. Folpe AL. Hum Pathol. 2024 May;147:114-128. doi: 10.1016/j.humpath.2024.01.014. Epub 2024 Feb 13. Hum Pathol. 2024. PMID: 38360216 Review.
The term "hemangioendothelioma" is used for endothelial neoplasms of intermediate malignancy and describes a group of rare neoplasms having biologic behavior falling in between that of the benign hemangiomas and fully malignant angiosarcomas. The hemangioendothel
The term "hemangioendothelioma" is used for endothelial neoplasms of intermediate malignancy and describes a group of rare neoplasms …
5,027 results